HALO Clinical AI Flyer
Check out our flyer to learn more about HALO Clinical AI Solutions
HALO Clinical AI Flyer Read More »
HALO Clinical AI
Low and Ultralow HER2 Expression in Breast Cancer is Now Detectable by Indica Labs’ Breast IHC AI
Albuquerque, NM, April 30, 2025 – Indica Labs, the leading provider of AI-powered digital pathology solutions, announces today an update to their Breast IHC AI suite, an image analysis tool used for the quantification of HER2, ER, PR, and Ki67 within AI-identified, tumor regions, of breast cancer tissue specimens. The HER2 algorithm will now include functionality for the detection of low and ultralow HER2 expression in breast cancer.
Indica Labs Expands their Macrodissection Suite with the Launch of CRC Macrodissect AI
Indica Labs, the leading provider of AI-powered digital pathology solutions, announces today the expansion of their macrodissection suite with the launch of CRC Macrodissect AI.
Indica Labs Expands their Macrodissection Suite with the Launch of CRC Macrodissect AI Read More »
Open Pathology and AI Integrations: Empowering Labs with Choice
In digital pathology, advancements and proliferation in artificial intelligence (AI) and digital laboratory equipment are enabling streamlined workflows and new insights. However, they can also multiply the potential challenges laboratories face with software integration.
Open Pathology and AI Integrations: Empowering Labs with Choice Read More »
CRC Macrodissect AI and Breast HER2 AI Sneak Peek
27 March 2025 | Learn about the latest advancements in AI-powered pathology. In this webinar, we’ll introduce CRC Macrodissect AI, an advanced solution designed to assist in colorectal cancer tumor content scoring and selecting regions for downstream macrodissection.
CRC Macrodissect AI and Breast HER2 AI Sneak Peek Read More »
Looking Back: Reviewing 2024 at Indica Labs
As 2024 draws to a close, we at Indica Labs would like to thank the customers and collaborators who helped fill 2024 with exciting discoveries, events, and partnerships. It is a great honor to have played a part in customers’ contributions to scientific fields ranging from immuno-oncology to infectious disease, immunology, neuroscience, and metabolism.
Looking Back: Reviewing 2024 at Indica Labs Read More »
The Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP) Selects Indica Labs’ HALO AP® to Deliver AI-enabled Diagnostics
Albuquerque, NM, October 30, 2024 – The Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), among the leading institutes for clinical digital pathology and research in the European Union, has partnered with Indica Labs to implement digital primary diagnostics with integrated AI-powered image analysis.
Indica Labs’ London HALO® User Group Meeting 2024
10 December 2024 | Indica Labs is pleased to announce our London HALO User Group Meeting to be held in London on 10 December 2024 at Hilton London Metropole from 12:00 – 16:00.
Indica Labs’ London HALO® User Group Meeting 2024 Read More »
2024 Pathology Visions Pre-Conference Workshop Abstract for Indica Labs
3 November 2024 | In this one-hour pre-conference workshop, Indica Labs is pleased to host Dr. Eun Yeong Oh, MD, PhD, Assistant Regional Medical Director, Subchief of Breast Pathology, and Physician AI Champion at Mid-Atlantic Permanente Medical Group (MAPMG), who will present on the validation and implementation of a laboratory developed test using Breast IHC AI in the HALO AP® platform.
2024 Pathology Visions Pre-Conference Workshop Abstract for Indica Labs Read More »
HALO AP® and HALO AP Dx: Pathologist-Centric Enterprise Digital Pathology Platforms
10 October 2024 | Join us for this 1-hour webinar to learn about HALO AP platforms with regulatory clearances supporting diagnostic workflows in the US (FDA cleared HALO AP Dx) and in the EU and UK (CE-IVDR marked HALO AP®).
HALO AP® and HALO AP Dx: Pathologist-Centric Enterprise Digital Pathology Platforms Read More »